DKSH and Proveris Scientific Corporation enter into an exclusive distribution agreement for Malaysia and Thailand DKSH

Underlining the strategic direction of solidifying its position as a leading pan-Asian provider of scientific instrumentation, DKSH Business Unit Technology has exclusively partnered with Proveris Scientific Corporation. As part of the agreement, DKSH will obtain exclusive distribution rights of testing solutions to advance the science of nasal and inhaled drug delivery in Malaysia and Thailand.

Media release

Bangkok, November 30 2020 – DKSH Business Unit Technology and Proveris Scientific Corporation have signed an exclusive distribution agreement to promote testing solutions that drive forth the science of nasal and inhaled drug delivery in Thailand and Malaysia.

Understanding the challenges faced by manufacturers of Orally Inhaled and Nasal Drug Products (OINDPs), Proveris Scientific Corporation's measurement systems, advanced technologies and laboratory services enable customers to successfully develop and bring their products to market. Its worldwide customer base includes the top innovator and generic pharmaceutical companies, device manufacturers and regulatory agencies. Committed to quality, its products are manufactured in conformance with ISO 9001 quality guidelines and processes. Its measurement systems are certified to the ISO 9001:2015 standard by TUV Rheinland of North America.

Ben Okorodudu, Vice President, Sales, Proveris Scientific Corporation, stated: “We believe that the DKSH team will bring value to the customers in Thailand and Malaysia through great market coverage, service and access to our range of measurement systems and laboratory services. We look forward to a great partnership.”

Gabriela Gillot, Business Development Manager, Scientific Instrumentation, DKSH Technology, commented: “We are pleased to exclusively partner with Proveris Scientific Corporation in Thailand and Malaysia. Their innovative technologies complement our existing product portfolios, enabling us to offer integrated solutions to our customers, especially in the pharmaceutical industry. Leveraging our extensive sales coverage, channel management and unparalleled after-sales services, we are convinced that we can successfully drive market share growth.”

For further information, please contact:

Business Unit Technology

Irene Chen

Director, Group Marketing

Phone +886 2 8752 7611

irene.yr.chen@dksh.com